Natasha Emer
Senior Finance Manager
Professional Overview
Natasha Emer is a seasoned finance professional with over 20 years of experience in the pharmaceutical and consumer goods industries. As a Senior Finance Manager at Celgene, she leverages her deep expertise in financial analysis, strategic planning, and operational optimization to drive business growth and profitability.
Experience Summary
Current Role
As the Senior Finance Manager at Celgene since 2021, Natasha is responsible for overseeing the company's financial reporting, budgeting, and forecasting processes. She works closely with cross-functional teams to identify and implement cost-saving initiatives, optimize resource allocation, and enhance financial controls. Natasha's strategic insights and analytical prowess have been instrumental in supporting Celgene's expansion and navigating complex regulatory and market dynamics.
Career Progression
Prior to her current role, Natasha held various senior financial analyst positions at industry-leading organizations, including inVentiv Health, Johnson & Johnson, and Bayer Consumer Care. In these roles, she demonstrated exceptional financial modeling and data analysis skills, contributing to the success of complex projects and driving operational improvements. Natasha's ability to translate financial data into actionable insights and her collaborative approach have been key to her professional growth and impact.
Academic Background
Natasha holds a Bachelor of Science in Finance from Rutgers University, where she graduated with Honors. She is a Certified Public Accountant (CPA) and has completed executive training programs in financial management and strategic decision-making.
Areas of Expertise
- Financial planning and analysis
- Budgeting and forecasting
- Cost optimization and operational efficiency
- Financial reporting and controls
- Cross-functional collaboration and project management
- Regulatory compliance and risk management
Professional Impact
During her tenure at Celgene, Natasha has played a pivotal role in streamlining the company's financial processes, resulting in a 15% reduction in operating expenses. She has also spearheaded the implementation of a robust financial reporting system, providing real-time insights that have enhanced decision-making and strategic planning. Natasha's contributions have been recognized through her selection as a finalist for the prestigious CFO of the Year award.
Conclusion
Natasha Emer is a highly analytical and results-oriented finance professional with a proven track record of driving business success in the pharmaceutical industry. Her combination of technical expertise, strategic thinking, and collaborative approach positions her as a valuable asset to Celgene as the company continues to navigate the evolving market landscape.
